Cart
sales@molnova.com
HBV-IN-37
CAS No. 380483-01-2
HBV-IN-37( —— )
Catalog No. M37076 CAS No. 380483-01-2
HBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 42 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 50MG | 102 | In Stock |
|
| 100MG | 152 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHBV-IN-37
-
NoteResearch use only, not for human use.
-
Brief DescriptionHBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research.
-
DescriptionHBV-IN-37 is an inhibitor of HBV with an EC50 value of 10 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number380483-01-2
-
Formula Weight439.96
-
Molecular FormulaC23H22ClN3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N1C(C=2C(=NN(C2)C3=CC=CC=C3)C4=CC=C(Cl)C=C4)SCC1=O)C5CCCO5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
RG7834
RG7834 is a highly selective and orally bioavailable inhibitor of HBV(HBsAg and HBeAg and HBV DNA with IC50s of 2.8, 2.6, and 3.2 nM, respectively, in dHepaRG Cells).
-
Besifovir
Besifovir (PMCDG Dipivoxil, NA-380, LB-80380) is a potent, selective, orally available anti-HBV agent, the prodrug of PMCDG (EC50=4 uM).
-
Pamidronate disodium...
Pamidronate disodium, a bisphosphonate drug, can help to strengthen bones.
